Back to Results
First PageMeta Content
Ulipristal acetate / Emergency contraception / Progesterone / Mifepristone / Levonorgestrel / Contraception / Progestin / Birth control / Selective progesterone receptor modulator / Hormonal contraception / Endocrine system / Medicine


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived
Add to Reading List

Open Document

File Size: 207,05 KB

Share Result on Facebook

Company

UPI / HRA Pharma / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

product labeling/healthcare provider education / /

MedicalCondition

infection / /

MedicalTreatment

Emergency Contraception / /

Organization

Advisory Committee for Reproductive Health Drugs / U.S. Food and Drug Administration / /

Person

Scott Monroe / /

Position

Director / Division of Reproductive and Urologic Products / /

Product

One tablet / Plan B One-Step One / One-Step One tablet / levonorgestrel / Preven 2 / estradiol / Progestin LNG 1.5 / Plan B/ Generic Plan B One / misoprostol / Contraception Drug / US / FDA-Approved Drug / /

SocialTag